In the absence of a clearly identifiable cause, the prognosis of @entity1 with @entity401 is grim. This study describes our institutional experience in management of @entity1 who are admitted to an ICU with @entity1576 secondary to @entity16058 ( @entity16058 ). This study was performed to obtain Australian data on @entity1 admitted to an ICU with @entity1576 secondary to @entity16058 . This is a retrospective cohort study of @entity1 with @entity16058 who were admitted to the ICU between December 2007 and December 2013 at one of two university-affiliated academic hospitals in Newcastle, New South Wales. Thirty-six @entity1 (69% male) were admitted to the ICU in @entity1576 from @entity16058 . The median age of the cohort was 71 (66 to 77) years. The median APACHE III score was 68 (56 to 97). Sixty-nine percent (25/36) of @entity1 died in hospital. The median ICU and hospital lengths of stay were 6 (2 to 13.5) and 12 (4.8 to 18.3) days respectively. No significant difference was observed between admission characteristics and mortality. @entity1 admitted to ICU with @entity1576 secondary to @entity16058 are aggressively investigated and treated, but still have a high mortality rate. Accurate predictors of mortality would be useful in offering aggressive treatment to @entity1 who would benefit from it.

XXXX in the ICU: an observational cohort.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity1576 :: ('MESH:D012131', 'Disease') :: ['respiratory failure', 'respiratory insufficiency'] @entity16058 :: ('MESH:D054988', 'Disease') :: ['idiopathic interstitial pneumonia', 'IIP'] @entity401 :: ('MESH:D017563', 'Disease') :: ['interstitial lung disease']
@entity16058 :: (MESH:D054988,Disease) :: ['Idiopathic interstitial pneumonia']
